Apollo Endosurgery Inc
NASDAQ:APEN
Apollo Endosurgery Inc
NASDAQ:APEN
Price:
10 USD
Market Closed
Updated:
May 3, 2024
Apollo Endosurgery Inc
Cash from Financing Activities
|
Apollo Endosurgery Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Apollo Endosurgery Inc
NASDAQ:APEN
|
Cash from Financing Activities
$349k
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
-33%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Apollo Endosurgery Inc's Cash from Financing Activities?
Cash from Financing Activities
349k
USD
349k
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Cash from Financing Activities amounts to 349k USD.
What is Apollo Endosurgery Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-33%
-33%
Over the last year, the Cash from Financing Activities growth was -99%. The average annual Cash from Financing Activities growth rates for Apollo Endosurgery Inc have been -77% over the past three years , -58% over the past five years , and -33% over the past ten years .
You don't have any saved screeners yet
